REXO2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.144800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.214200E-01
Normal-vs-Stage2
2.694800E-01
Normal-vs-Stage3
5.177400E-01
Normal-vs-Stage4
1.602180E-01
Stage1-vs-Stage2
2.633000E-01
Stage1-vs-Stage3
6.360000E-01
Stage1-vs-Stage4
1.838810E-01
Stage2-vs-Stage3
6.331800E-01
Stage2-vs-Stage4
8.811600E-01
Stage3-vs-Stage4
5.909200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.217600E-01
Normal-vs-AfricanAmerican
1.378990E-01
Normal-vs-Asian
4.076000E-01
Caucasian-vs-AfricanAmerican
9.325800E-01
Caucasian-vs-Asian
9.463200E-01
AfricanAmerican-vs-Asian
9.072200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.089400E-01
Normal-vs-Female
3.146400E-01
Male-vs-Female
3.709000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.151600E-01
Normal-vs-Age(41-60Yrs)
2.258200E-01
Normal-vs-Age(61-80Yrs)
3.609200E-01
Normal-vs-Age(81-100Yrs)
2.834400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.736580E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.554400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.208600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.252300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.282200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.728600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.214200E-01
Normal-vs-Daily Drinker
4.777200E-01
Normal-vs-Weekly Drinker
2.139000E-01
Normal-vs-Occasional Drinker
9.993900E-02
Normal-vs-Social Drinker
4.123200E-01
Non Drinker-vs-Daily Drinker
4.828600E-01
Non Drinker-vs-Weekly Drinker
8.159400E-01
Non Drinker-vs-Occasional Drinker
6.840000E-01
Non Drinker-vs-Social Drinker
2.957200E-01
Daily Drinker-vs-Weekly Drinker
5.850000E-01
Daily Drinker-vs-Occasional Drinker
1.932800E-01
Daily Drinker-vs-Social Drinker
7.802600E-01
Weekly Drinker-vs-Occasional Drinker
4.533800E-01
Weekly Drinker-vs-Social Drinker
3.465400E-01
Occasional Drinker-vs-Social Drinker
7.969900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.989000E-01
Normal-vs-Grade 2
9.902200E-01
Normal-vs-Grade 3
9.359400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.93309999999758E-05
Grade 1-vs-Grade 3
2.951300E-04
Grade 1-vs-Grade 4
7.989000E-01
Grade 2-vs-Grade 3
3.679200E-01
Grade 2-vs-Grade 4
9.902200E-01
Grade 3-vs-Grade 4
9.359400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.332400E-01
Normal-vs-NonDiabetic
3.276200E-01
Diabetic-vs-NonDiabetic
9.659400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.466350E-01
Normal-vs-NoPancreatitis
3.287200E-01
Pancreatitis-vs-NoPancreatitis
2.790200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.495600E-01
Normal-vs-N1
2.812400E-01
N0-vs-N1
2.729800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.464400E-02
Normal-vs-TP53-NonMutant
8.635200E-01
TP53-Mutant-vs-TP53-NonMutant
9.10280000265828E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
